Revive Therapeutics Ltd (RVV.CN)
0.0100 unch (unch) 09:31 ET [CNSX]
0.0050 x 14,660,000 0.0100 x 3,131,000
Realtime by (Cboe BZX)
0.0050 x 14,660,000 0.0100 x 3,131,000
Realtime - - (-) -
for Mon, Jan 27th, 2025
Fiscal Year End Date: 06/30
(Values in thousands)
06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
Operating Expenses | 3,286 | 5,521 | 17,833 | 18,592 | 3,684 |
Operating Income | -3,286 | -5,521 | -17,833 | -18,592 | -3,684 |
Interest Expense | 20 | 44 | 63 | 79 | 88 |
Other Income | -2,312 | -756 | 90 | -1,447 | -1,610 |
Pre-tax Income | -5,619 | -6,321 | -17,807 | -20,119 | -5,382 |
Net Income Continuous | -5,619 | -6,321 | -17,807 | -20,119 | -5,382 |
Net Income | $-5,619 | $-6,321 | $-17,807 | $-20,119 | $-5,382 |
EPS Basic Total Ops | -0.01 | -0.02 | -0.06 | -0.08 | -0.05 |
EPS Basic Continuous Ops | -0.01 | -0.02 | -0.06 | -0.08 | -0.05 |
EPS Diluted Total Ops | -0.01 | -0.02 | -0.06 | -0.08 | -0.05 |
EPS Diluted Continuous Ops | -0.01 | -0.02 | -0.06 | -0.08 | -0.05 |
EBITDA(a) | $-5,598 | $-6,276 | $-17,743 | $-20,039 | $-5,266 |